23 May 2013
Keywords: aredia, bone, metastases, breast, cancer, chiron, therapeutics
Article | 19 August 1996
Chiron Therapeutics and Ciba have been granted approval in the USA to
market their bisphosphonate drug Aredia (pamidronate disodium for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 August 1996
12 August 1996
22 May 2013
© 2013 thepharmaletter.com